Words like "indicate" and "clinically meaningful" imply that the study was a success. But it wasn't--at least not by commonly accepted biotech standards requiring statistical significance.
And maybe that's why the stock was not able to hold its early gains.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.